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ABSTRACT Reducing Campylobacter spp. carriage
in poultry is challenging, but essential to control this
major cause of human bacterial gastroenteritis world-
wide. Although much is known about the mechanisms
and route of Campylobacter spp. colonization in poul-
try, the literature is scarce on antibiotic-free solutions
to combat Campylobacter spp. colonization in poultry.
In vitro and in vivo studies were conducted to investi-
gate the role of TYPLEX R© Chelate (ferric tyrosine), a
novel feed additive, in inhibiting Campylobacter jejuni
(C. jejuni) biofilm formation and reducing C. jejuni and
Escherichia coli (E. coli) colonization in broiler chickens
at market age. In an in vitro study, the inhibitory ef-
fect on C. jejuni biofilm formation using a plastic bead
assay was investigated. The results demonstrated that
TYPLEX R© Chelate significantly reduces biofilm forma-
tion. In an in vivo study, 800 broilers (one d old) were
randomly allocated to 4 dietary treatments in a ran-
domized block design, each having 10 replicate pens
with 20 birds per pen. At d 21, all birds were chal-
lenged with C. jejuni via seeded litter. At d 42, cecal
samples were collected and tested for volatile fatty acid
(VFA) concentrations and C. jejuni and E. coli counts.
The results showed that TYPLEX R© Chelate reduced
the carriage of C. jejuni and E. coli in poultry by 2
and 1 log10 per gram cecal sample, respectively, and in-
creased cecal VFA concentrations. These findings sup-
port TYPLEX R© Chelate as a novel non-antibiotic feed
additive that may help produce poultry with a lower
public health risk of Campylobacteriosis.
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INTRODUCTION
Campylobacter spp. infections are a major cause
of human bacterial gastroenteritis and pose a serious
health burden worldwide, accounting for 400 to 500 mil-
lion cases of diarrhea each year (Ruiz-Palacios, 2007).
A significant proportion of health care costs are as-
sociated with sequelae linked to Campylobacteriosis,
such as Guillain-Barre´ syndrome, reactive arthritis, and
irritable bowel syndrome (WHO, 2013). Despite sev-
eral government programs and awareness campaigns
to reduce Campylobacter spp., little reduction is re-
ported in the numbers of the bacterium in animals
and/or animal products in retail outlets (Robyn et al.,
2015). It is estimated that foodborne transmission con-
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tributes to 58% of the global disease burden (Hald
et al., 2015).
Chicken, pork, and beef are reported as significant
foodborne sources of Campylobacter with presence of
the pathogen at high concentrations found through-
out the food chain (Miller and Mandrell, 2005). The
strong adhesion capability of Campylobacter strains
could partly explain the rapid cross-contamination or
re-contamination of food products, and may be the
most significant mode of survival for Campylobacter in
the food chain (Sulaeman et al., 2010).
Campylobacter infection is dependent on motility me-
diated by polar flagella A (FlaA) and adhesion and
biofilm-promoting ability of the major outer membrane
protein (MOMP) (Ashgar et al., 2007; Muller et al.,
2007; Min et al., 2009; Mahdavi et al., 2014). Consid-
ering such idiosyncrasy, it is easy for Campylobacter to
colonize live animals and survive transitionally in the
food chain or in biofilms before reaching the intesti-
nal tract of humans (Buswell et al., 1998; Trachoo and
Frank, 2002; Miller and Mandrell, 2005; Lehtola et al.,
2006; Sanders et al., 2008).
Biofilms are accumulations of microorganisms em-
bedded in an extracellular matrix (ECM), which
adheres to solid biological or non-biotic surfaces
(Costerton, 1995; Kalmokoff et al., 2006). The ECM
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comprises proteins, polysaccharides, nucleic acids, and
phospholipids (Stoodley et al., 2004). Foodborne bac-
terial pathogens either can form biofilms on inert sur-
faces or can reach and integrate into pre-established
biofilms.
Increase in cecal volatile fatty acid (VFA) concen-
trations, indicating fermentation by anaerobic bacte-
ria, are found to be negatively correlated with the
number of Enterobacteriaceae in broiler chickens (Van
Der et al., 2000; Kubena et al., 2001). Several strate-
gies such as reduction of environmental exposure to
Campylobacter by hygiene and biosecurity measures,
water treatment, use of plant-derived feed additives,
use of bacteriophage, bacteriocin therapies, vaccina-
tion, passive immunization, use of pre- and probiotics,
and genetic selection have been investigated to control
on-farm Campylobacter contamination (Sahin et al.,
2003; Chaveerach et al., 2004; Carrillo et al., 2005;
Calderon-Gomez et al., 2009; Lin, 2009; Buckley et al.,
2010; Hermans et al., 2010; Svetoch and Stern, 2010;
Hermans et al., 2011). Despite all these efforts, Campy-
lobacter remains a major cause of human gastroenteri-
tis and a priority for the development of new control
strategies. In addition, use of antibiotics in both an-
imal and human medicine can influence the develop-
ment of antibiotic-resistant Campylobacter and is in-
creasingly becoming a challenge for food safety and
public health (Luangtongkum et al., 2009). The authors
postulated that the novel feed additive, TYPLEX R©
Chelate, a synthetic complex of L-tyrosine and Fe (III),
exerts a unique action on enteropathogens by prevent-
ing the formation of biofilms at chyme/mucosal and
other interfaces. Based on the non-antimicrobial nature
of ferric tyrosine, the current studies were designed to
demonstrate that TYPLEX R© Chelate inhibits C. jejuni
biofilm formation (in vitro), increases cecal VFA con-
centrations (in vivo), and thus has an ability to reduce




TYPLEX R© Chelate (Akeso Biomedical, Inc.,
Waltham, MA), a complex containing tyrosine and
iron (ferric tyrosine), was the novel feed additive used
in these studies.
Experimental Diets
Basal iso-nitrogenous and iso-energetic wheat-
soyabean meal control diets (T1) were manufactured
as one batch for each feeding phase, i.e., starter (day
0 to 21) and grower (day 21 to 42). Three additional
treatments (T2 to T4) were generated by addition of
TYPLEX R© Chelate to T1 at 0.02, 0.05, and 0.20 g/kg
feed, respectively. Diets were manufactured with coc-
cidiostats but contained no veterinary antibiotics. The




(d 0 to 21)
Grower diets
(d 21 to 42)
Barley 10.415 8.315
Wheat 50 55
Soya Ext Hipro 26 23
Full fat Soya Cherwell 5 5
L Lysine HCl 0.4 0.3
DL-methionine 0.4 0.35
L-threonine 0.15 0.15
Soya Oil 4 4.5
Limestone Trucal 52 1.25 1.25
Monocalcium phosphate 1.5 1.25
Salt 0.25 0.25
Sodium bicarbonate 0.15 0.15
Broiler Premix∗ 0.4 0.4
















Total lysine 1.43 1.28
Available lysine 1.33 1.19
Methionine 0.69 0.62





Available phosphorus 0.48 0.42
Sodium chloride 0.30 0.30
Sodium 0.17 0.17
Analyzed nutrient composition
Dry matter 88.1 88.2
Crude protein† 21.8 20.7
Ether extract 6.66 7.12
Iron (mg/kg) 135 99
∗Premix provided per kg: vitamin A, 2,400 IU; vitamin D3, 1,000 IU;
vitamin E, 10,000 IU; vitamin K3, 600 mg/kg; vitamin B1, 400 mg/kg;
vitamin B2, 1,400 mg/kg; pantothenic acid, 3,000 mg/kg; nicotinic acid,
10,000 mg/kg; vitamin B6, 1,000 mg/kg; vitamin B12, 3,000 μg/kg;
folic acid: 200 mg/kg; biotin: 40 mg/kg; copper, 2,000 mg/kg; zinc,
16,000 mg/kg; manganese, 20,000 mg/kg; iodine , 200 mg/kg; selenium,
40 mg/kg; choline choride, 500 g: No added iron in premix.
†Crude protein = Nitrogen x 6.25.
ingredients, premixes, and the calculated analy-
ses of the starter and grower diets are presented
in Table 1. Diets were analyzed for dry mat-
ter, nitrogen, ether extract, and iron. Total nitro-
gen content of diet was determined by the com-
bustion method (AOAC Method 968.06), whereas
ether extract was determined in a soxhlet extrac-
tor (AOAC Method 922.06). Iron content was de-
termined using inductively coupled plasma–optical
emission spectroscopy (AOAC Method 990.08) follow-
ing digestion, in turn, in concentrated nitric and hy-
drochoric acid. Colored tracers (Micro-Tracers Inc, San
Francisco, CA) were added to TYPLEXTM Chelate at
10% w/w, to enable visual confirmation of TYPLEXTM
Chelate content and uniform mixing in feed samples.
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In vitro assessment of C. jejuni biofilm
inhibition in a simulated gut environment
using a plastic bead assay
A plastic bead assay (O’Toole and Kolter, 1998;
Stepanovic et al., 2000) with some modifications for
suitability with C. jejuni was carried out in vitro to
show that the TYPLEX R© Chelate extracted from the
experimental diets has an inhibitory effect on C. jejuni
biofilm formation.
Extraction of TYPLEX R© Chelate from the exper-
imental diets. 10 g aliquots of feed from all experi-
mental diets (T1 to T4) for each phase were homog-
enized to very fine particles (around 100 μm) and
mixed with 50 mL (1:5) of buffer (20 mM KCl/HCl; pH
3.4). The feed/buffer mixtures were autoclaved (high-
pressure saturated steam at 121◦C for around 15 to
20 min, 3 cycles). The high heat and pressure of the au-
toclave resulted in extraction of the TYPLEX R© Chelate
from the feeds while retaining its physical properties.
The resulting suspensions were then filtered using filter
paper (25 μm filter). The pH of all filtered samples was
measured and found to be between 6.2 and 6.5.
Bead assay. C. jejuni strain NCTC11168 was
grown overnight in 3 mL of sterile brain heart infusion
(BHI) broth under microaerophilic conditions (85% ni-
trogen, 10% carbon dioxide, and 5% oxygen) at 42◦C
on modified Campylobacter-selective charcoal cefoper-
azone desoxycholate (CCDA). The optical density at
a wavelength of 600 nm (OD600) of these cultures was
measured, then the cultures were used to inoculate a
feed extract + BHI suspension (1:4 dilution) to achieve
a final OD600 of 0.02.
Two sterile plastic beads per dietary treatment were
placed into 2.5 mL of BHI, with 0.5 mL of the extracted
feeds and inoculated with C. jejuni. The beads were
then incubated at 42◦C for 48 hours. Following incuba-
tion, the beads were gently washed twice (5x dipping
each) in phosphate buffered saline (PBS), placed into
1 mL of PBS, and vigorously vortexed for 30 s prior to
centrifuging at 3,000 rpm. The PBS containing bacte-
rial cells released from the biofilm was serially diluted,
and 3 × 5 μl aliquots of each dilution were spotted
onto CCDA agar plates for quantification (Thermo-
Fisher plates, 3 plates/bead, 2 beads/treatment, 6
samples/treatment). The plates were subsequently in-
cubated microaerophilically at 42◦C for 48 h, and
colonies were counted and expressed as cfu/mL. The
same experiment was carried out in triplicate.
Seeder litter challenge to colonize chicken
with C. jejuni in vivo
To confirm in vitro findings, an in vivo study was de-
signed to investigate the efficacy of TYPLEX R© Chelate
under farm conditions. A total of 800 male broiler chick-
ens (Ross 308) was allocated randomly to pens in 4
dietary treatments (T1 to T4), with pens distributed
using a randomized complete block design. Each treat-
ment had 10 replicate floor pens with 20 chicks per pen.
Birds were reared on fresh wood shavings in clean pens
having European Union maximum stocking density at
42 d of 38 kg/m2. At 21 d of age, all birds were chal-
lenged with C. jejuni seeded litter. Diets were fed ad
libitum for 42 d in mash form; body weight and feed
intake of each replicate pen were recorded to calculate
the global zootechnical data (d 0 to 39). At the end of
the study (d 42), all birds were humanely killed through
cervical dislocation, and cecal samples were collected
from 10 birds/pen and used for C. jejuni and E. coli
enumeration, and 2 birds/pen for cecal VFA analysis.
The in vivo study (AU AE 37–2016) was carried out
under the Animals Scientific Procedures Act (1986) and
approved by the ethical review committee of Scotland’s
Rural College (SRUC).
Seeded litter challenge procedure. Approxi-
mately 20 kg of used poultry litter was taken from a
recently completed broiler study. The litter (not tested
for any pathogen) was placed in an oven at 80◦C until a
constant weight was obtained, then divided into 400 g
batches in 40 trays (each tray was approximately 38 ×
28 × 8 cm). Each dried reused litter tray was recon-
stituted with 1,000 mL of deionized water. Trays were
then seeded with a mixture of Mueller-Hinton (MH)
broth, Campylobacter suspension (4.5 × 105 cfu C. je-
juni/mL), and dried hen droppings (20 mL: 10 mL:
10 g). The hen droppings were dried in the same way
as the litter. Campylobacter isolates were obtained from
cecal samples taken from 3 different commercial poul-
try farms and stored at -80◦C in bead cryopreserva-
tion vials (Technical Service Consultants, Lancashire,
UK). C. jejuni (individual strains were not identified)
were resuscitated on blood agar (BA) No. 2 with horse
blood plates (Oxoid PB0114). These cultures were used
to prepare lawn plates on further BA plates, incu-
bated for 40 to 48 h at 41.5◦C, in boxes with a mi-
croaerophilic atmosphere generation system (Campy-
Gen, Oxoid, Hampshire, UK). The lawn plates were
harvested by adding 5 mL MH broth, gently detaching
the culture with a sterile spreader, and decanting to a
container. The suspension was then adjusted with fur-
ther MH broth to OD600 of 0.19 to 0.21 (approximately
1.5 × 105 cfu.ml−1). The bacterial suspension, broth,
and droppings were mixed and spread evenly on the
top of the litter tray. The tray was then placed in a pen
near the feeder.
Isolation and enumeration of C. jejuni from ceca.
A sterile scalpel was used to cut off the blind end of
both cecal sacks from each chicken. For each sample,
0.5 g of content from each cecal sac (in total 1 g) was
weighed out into sterile universal bottles. At each sam-
pling, a total of 2 g cecal content was diluted with
4 mL of sterile maximum recovery diluent (MRD),
which was added to each universal container and mixed
thoroughly. This constituted the 1:2 dilutions (w/v). A
further 8 serial dilutions were made in MRD. Then,
5 to 10 μL of each dilution were spotted on CCDA,
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De Man, Rogosa and Sharpe (MRS), Brilliance, or chro-
mogenic plates (Oxoid PO0119) and left to dry. Plates
were incubated microaerophilically at 41.5◦C ± 2.0◦C
for 24 to 48 hours. Following incubation, plates were
assessed for the presence or absence of thermotolerant
Campylobacter species. In addition, plates of an ap-
propriate dilution level were selected and colonies enu-
merated. As a confirmatory measurement, 2 colonies
from each presumptively positive plate were selected
and sub-cultured onto paired blood agar plates (Ox-
oid PB0114). These plates were incubated at 37◦C for
48 h, one plate aerobically and one plate microaerophili-
cally. The presence of C. jejuni was indicated by lack
of growth aerobically and colonies with Campylobac-
ter morphology that grew microaerophilically. In addi-
tion, Gram stains were performed on all presumptively
Campylobacter positive samples. Oxidase strips (Oxoid
MB0266) were used to further confirm that the samples
were oxidase positive.
In the case of pre-inoculation testing, at d 16, cloacal
swabs (one bird/pen) and overshoes (one overshoe/pen)
were tested for presence and absence of C. jejuni using
the same procedure as reported for C. jejuni enumera-
tion.
Cecal volatile fatty acid analysis The cecal digesta
were gently flushed out in 30 mL universal sample con-
tainers and immediately stored at -80◦C until analyzed.
Samples were ground in the presence of solid CO2 to en-
sure homogeneity. They were then shaken with a known
volume of water to extract the fatty acids. The extracts
were spiked with 4-methylvaleric acid as an internal
standard and then passed to gas chromatography (HP
5890 Series II GC; Agilent J & W 30 m × 0.535 mm ×
1.00 micon HP-FFAP column; FID detector) to deter-
mine the individual component composition by compar-
ison with a series of standard solutions that also were
spiked with an internal standard. Acetic, n-butyric,
propanoic, n-valeric, iso-butyric, and iso-valeric acid
were detected, and results were expressed as mg/kg.
Statistics
For the in vitro tests, a single 5 μl aliquot extracted
from a bead in a serially diluted manner, grown on
a CDDA plate, was the statistical unit of measure-
ment. A randomized complete block design with 10
blocks and 4 treatments was used for in vivo studies.
The individual bird sampled was the experimental unit
for microbiological (C. jejuni and E. coli) and VFA
analysis, whereas the pen was the experimental unit
for growth performance data. The microbiological data
were log10 transformed prior to analysis. Data obtained
were subjected to analysis of variance (ANOVA) us-
ing a GenStat 16 statistical software package (IACR,
Rothamstead, Hertfordshire, UK). Significance among
treatments was determined using orthogonal polyno-
mial contrasts. Where correlations are presented (iden-
tified using Genstat), all r2 are significant to at least















T1 0 0 0
T2 0.02 0.02 0.02
T3 0.05 0.06 0.04
T4 0.20 0.19 0.26
Table 3. Inhibitory effect of TYPLEX R© Chelate on C. jejuni












T1 versus T2 <0.001 <0.001
T1 versus T3 <0.001 <0.001
T1 versus T4 <0.001 <0.001
Linear <0.001
No. replicates/treatment = 18; cfu = colony forming units.
SEM = standard error of the mean.
T1 = Control (HCl/KCl) ; T2 = 0.02 g/kg TYPLEX R© Chelate ; T3
= 0.05 g/kg TYPLEX R© Chelate; T4 = 0.20 g/kg TYPLEX R© Chelate.
P < 0.05 unless otherwise stated. All statements of sig-
nificance are based on the probability level of P ≤ 0.05.
RESULTS
Nutrient composition and analyzed TYPLEX R©
Chelate of the experimental diets were within the ex-
pected range and are presented in Tables 1 and 2, re-
spectively.
Inhibitory Impact of Extracted TYPLEX R©
Chelate from Feeds on C. Jejuni Biofilm
Formation
In vitro data showed that the addition of TYPLEX R©
Chelate significantly reduced the ability of C. je-
juni to adhere to plastic beads and form a biofilm
(Table 3). For the starter diet, the addition of
TYPLEX R© Chelate extract at all concentrations re-
duced linearly the number of C. jejuni cells compared
to the control group (0.5, 0.3, and 0.5 log10 cfu/g re-
duction, respectively, P < 0.001). Similar results were
observed for the grower diet; the addition of TYPLEX R©
Chelate extract at 0.02 g/kg, 0.05 g/kg, and 0.2 g/kg
reduced linearly the number of C. jejuni cells compared
to the control group (0.4, 1.4, and 1.0 log10 cfu/g reduc-
tions, respectively, P < 0.001).
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Table 4. Effect of dietary treatments on growth performance of broilers.1
Starter phase Grower phase Overall performance
(d 0 to 21) (d 21 to 39) (d 0 to 39)
AWG2 AFI3 FCR4 AWG AFI FCR AWG AFI FCR
Item (kg/bird) (kg/bird) (kg/kg) (kg/bird) (kg/bird) (kg/kg) (kg/bird) (kg/bird) (kg/kg)
Treatment
T1 0.773 1.077 1.400 0.381 2.948 1.611 2.618 4.025 1.544
T2 0.821 1.076 1.314 0.428 2.915 1.579 2.695 3.991 1.495
T3 0.776 1.024 1.327 0.461 2.865 1.533 2.660 3.890 1.471
T4 0.829 1.085 1.316 0.479 2.943 1.543 2.748 4.028 1.472
SEM 0.014 0.016 0.027 0.020 0.036 0.023 0.029 0.047 0.016
P-values for contrast5
T1 vs. T2 0.002 0.979 0.004 0.027 0.361 0.182 0.02 0.484 0.007
T1 vs. T3 0.842 0.003 0.012 <0.001 0.031 0.002 0.181 0.009 <0.001
T1 vs. T4 <0.001 0.584 0.005 <0.001 0.889 0.007 <0.001 0.94 <0.001
Linear 0.011 0.614 0.010 0.579 0.579 0.002 0.001 0.559 <0.001
1All means are average of 10 pens per treatment.
2AWG = Average weight gain.
3AFI = Average feed intake.
4FCR = Feed conversion ratio.
T1 = Control; T2 = 0.02 g/kg TYPLEX R© Chelate; T3 = 0.05 g/kg TYPLEX R© Chelate; T4 = 0.20 g/kg TYPLEX R© Chelate.
5Significance level (P ≤ 0.05).
Campylobacter Infection and Bird
Performance
The seeded litter challenge model was successful in
horizontal transfer of C. jejuni in birds within pens.
Pre-inoculation cloacal swabs and samples cultured
from overshoes were negative, whereas all cecal sam-
ples from all pens cultured positive for C. jejuni. The
growth performance of birds during the starter (d 0
to 21), grower (d 21 to 39), and overall growth period
(d 0 to 39) is presented in Table 4. During the pre-
challenge (starter phase), average weight gain (AWG)
of all birds fed the TYPLEX R© Chelate supplemented
diet was consistently higher compared to the T1 con-
trol group (P < 0.05). However, the differences were
significant only when birds fed T2 and T4 (0.02 and
0.20 g/kg TYPLEX R© Chelate) were compared with
T1 (P < 0.05). This improvement in AWG also re-
sulted into 3.6% lower (P < 0.05) mortality adjusted
feed conversion ratio (FCR) values compared with T1.
During the Campylobacter challenged period (grower
phase), all birds fed TYPLEX R© Chelate (T2, T3, and
T4) had 19.6% higher (P < 0.05) AWG compared to T1
(control group). This increase in AWG also was trans-
lated into 5.7% improvement in FCR of all birds fed
TYPLEX R© Chelate (T2, T3, and T4) supplemented di-
ets compared to the control group (T1). The average
feed intake (AFI) over the entire trial period was lower
(P < 0.05) for T3 (0.05 g/kg TYPLEX R© Chelate) com-
pared to T1 control. This shift in AFI resulted in signif-
icantly lower (P < 0.05) FCR for birds in the T3 group
compared to control. The overall growth performance
depicted similar trends and showed 2.9 and 4.9% linear
improvement (P < 0.05) in AWG in birds fed T2 and
T3 (0.02 and 0.20 g/kg TYPLEX R© Chelate), respec-
tively, and 4.1% lower (P < 0.05) FCR for birds fed all
TYPLEX R© Chelate diets (T2, T3, and T4) compared
Table 5. Cecal microbial counts at 42 d of age.1
Treatment Campylobacter spp.1 E. coli1







T1 vs. T2 0.005 0.002
T1 vs. T3 <0.001 <0.001
T1 vs. T4 <0.001 <0.001
Linear <0.001 <0.001
1All means are average of 20 (2 x culture plates/treatment). Campy-
lobacter spp. cultured on CCDAmedium, E. coli cultured on chromogenic
agar; CFU = colony forming unit; SEM = standard error of the mean;
T1 = Control; T2 = 0.02 g/kg TYPLEX R© Chelate; T3 = 0.05 g/kg
TYPLEX R© Chelate; T4 = 0.20 g/kg TYPLEX R© Chelate.
2Significant level (P ≤ 0.05).
to control (T1). The overall AWG and FCR values were
positively correlated (r2 = 0.693, 0.822, respectively; P
< 0.05), whereas AFI showed no correlation (r2 = 0.03;
P > 0.05) with the inclusion level of TYPLEX R© Chelate
in the diet. The birds remained healthy throughout
the experimental period, and the percentage mortal-
ity for treatments 1 to 4 was 6.0, 6.5, 3.5, and 6.5%, re-
spectively. Mortality was not associated with treatment
(P > 0.05).
Effect of TYPLEX R© Chelate on cecal C. jejuni
and E. coli colonization. Microbiological analyses of
cecal samples showed a 0.8, 2.1, and 2.1 log10 cfu/g
linear reduction (P < 0.05) in C. jejuni colonization
in TYPLEX R© Chelate supplemented T2, T3, and T4
treatment groups, respectively, compared to T1 control
(Table 5). Similarly, 0.6, 0.8, and 1.2 log10 cfu/g linear
reduction (P < 0.05) in E. coli counts was recorded in
birds that received 0.02, 0.05, and 0.20 g/kg TYPLEX R©
Chelate (T2, T3, and T4) compared with T1 control
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Table 6. Effect of experimental diets on the concentrations of volatile fatty acid (VFA; mg/kg) in the cecal content of broilers at
42 d of age.
Item Acetic acid n-Butyric acid Propionic acid n-Valeric acid Iso-valeric acid Iso-butyric acid Total VFA†
Treatment
T1 4785 1222 1048 179 214 126 7573
T2 6009 2139 1232 228 212 135 9954
T3 5979 2032 1199 255 310 175 9567
T4 5497 1728 1155 237 256 144 9018
SEM 387.9 188.9 95.2 30.3 37 18.09 622.4
P-values for contrast1
T1 vs. T2 0.003 <0.001 0.059 0.115 0.965 0.635 <0.001
T1 vs. T3 0.003 <0.001 0.118 0.015 0.012 0.009 0.002
T1 vs. T4 0.072 0.010 0.266 0.062 0.252 0.331 0.024
Linear 0.091 0.022 0.342 0.040 0.058 0.108 0.050
Means represents 2 birds per pen and 10 pens/treatment.
1Significance level (P ≤ 0.05).
SEM = Standard error of differences of means.
†Total VFA = sum of all individual volatile fatty acids (VFA).
(Table 5). The Campylobacter spp. and E. coli counts
were positively correlated with the inclusion level of
TYPLEX R© Chelate (r2 = 0.931, 0.952, respectively;
P < 0.05).
Effect of dietary TYPLEX R© Chelate on cecal VFA
concentrations. Individual and total VFA concentra-
tions in the cecal digesta are presented in Table 6. Total
VFA concentrations increased by 31 and 26% (P < 0.05)
in birds fed 0.02 and 0.05 g TYPLEX R© Chelate/kg
feed, respectively, compared to the control group. This
increase was due to a general increase in most acids.
Thus, feeding birds diets containing 0.02 and 0.05 g
TYPLEX R© Chelate/kg feed increased (P < 0.05) the
concentration of acetic acid by 26 and 24%, respectively,
compared to the non-supplemented T1 control. No ad-
ditional increase in acetic acid concentration was ob-
served when the inclusion rate of TYPLEX R© Chelate
was further increased from 0.05 to 0.20 g/kg feed. Pro-
pionic acid concentrations also were consistently higher
in birds fed TYPLEX R© Chelate diets, but the differ-
ences were not significant (P > 0.05) when compared
with the T1 control. Differences in the concentration of
n-butyric acid were more profound, and the concentra-
tion linearly increased (P < 0.05) by 75, 66, and 41% in
birds T2, T3, and T4 fed diets containing 0.02 and 0.05
and 0.20 g TYPLEX R© Chelate/kg feed, respectively,
compared with T1 control. Also, n-valeric, iso-butyric,
and iso-valeric acids were produced in very small quan-
tities, but followed the same trend, with significantly
greater concentrations in birds fed T3 diets containing
0.05 g TYPLEX R© Chelate/kg feed compared to T1 con-
trol.
DISCUSSION
The public health significance of C. jejuni infection
and emergence of multi-antibiotic resistant species of
Campylobacter demands development of new control
strategies in addition to farm biosecurity measures to
lower carriage of C. jejuni in live animals. To our knowl-
edge, this is the first study to report that TYPLEX R©
Chelate inhibits C. jejuni biofilm formation. The in
vitro assay showed that TYPLEX R© Chelate (extracted
from experimental diets) in a simulated gut environ-
ment reduced the ability of C. jejuni to adhere to plas-
tic beads and form a biofilm.
It is known that MOMP binds to multiple host cell
membranes by promoting biofilm formation and auto-
aggregation. It is the biofilm-forming ability of C. jejuni
that enables the organism to survive in the environment
and enter the food chain (Joshua et al., 2006). Based on
our in vitro results, it is likely that TYPLEX R© Chelate
inhibits FlaA and MOMP-mediated adhesion of C. je-
juni as evidenced by the reduction in biofilm formation.
The ability of C. jejuni to attach to surfaces and grow
in biofilms, where they are protected from antibiotics,
biocides, and other chemical or physical challenges,
is a key factor in persistence of infection in humans
(Costerton et al., 1999; Stewart, 2002; Stoodley et al.,
2004). As the TYPLEX R© Chelate inhibits biofilm for-
mation, it can therefore be helpful in farming and
food processing to reduce cross-contamination of food
products. This strategy offers an antibiotic-free method
that will not encourage the emergence of resistance in
pathogenic bacteria within the host organism. The in-
hibitory effect of TYPLEX R© Chelate on biofilm for-
mation showed the same pattern in starter and grower
diets.
The birds in the current study were challenged at
d 21 because Campylobacter spp. is rarely detected in
commercial flocks of less than 3 wk of age, regardless
of production methods (Kazwala et al., 1990), species
(Allen et al., 2011; Umar et al., 2016), or biosecurity
measures (Allain et al., 2014). The lag phase in col-
onization of poultry, even in the presence of positive
birds, suggests that a biological mechanism of coloniza-
tion resistance may be present in young birds due to
maternal antibodies (Cawthraw and Newell, 2010). The
relatively dry litter in the poultry house also may limit
the ability of Campylobacter to survive in the small vol-
ume of excreta produced by birds in the first few wk of
life (Sparks, 2016). However, when the flock is infected,
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the majority of birds become colonized within 4 to 7 d
after infection of the first bird (Sahin et al., 2015), and
the overall prevalence rises as high as 100% at slaughter
age (Barrios et al., 2006), without any apparent clinical
manifestations in the chicken host (Kaino et al., 1988).
The incidence of human Campylobacteriosis often is
associated with consumption of poultry products con-
taminated with C. jejuni and this, in turn, is linked to
the number of C. jejuni present in the ceca of the bird
(Wagenaar et al, 2006; Neal-McKinney et al., 2014). As
few as 500 cells of C. jejuni can cause infection (Black
et al., 1988). There is no evidence for a “safe” level
of Campylobacter contamination, as the minimum in-
fectious dose will always be strain-specific. In general,
it is considered that the risk of Campylobacteriosis in-
creases as the number of Campylobacter on the bird
increases (EFSA, 2009). Therefore, it is possible to re-
duce the incidence of human infection by lowering the
number of C. jejuni in birds bound for the food sup-
ply. In this study, use of TYPLEX R© Chelate in broiler
diets at 0.05 and 0.20 g/kg feed reduced the counts of
cecal C. jejuni by up to 2 log10 cfu/g sample the counts
of cecal C. jejuni in broilers aged 42 days. According
to food safety risk analysis studies, this level of reduc-
tion in colonization may be able to reduce the public
health risk associated with human Campylobacteriosis
(Rosenquist et al., 2003; EFSA, 2011).
One of the mechanisms known to reduce Enterobac-
teriaceae (Gram-negative bacteria) in the intestinal mi-
croflora is the bacteriostatic effect of VFA in the ceca
(Van Der et al., 2000). The current study showed that
feeding broilers diets supplemented with 0.02 and 0.05 g
TYPLEX R© Chelate/kg feed resulted in increased (P <
0.05) cecal concentrations of total VFA, mainly due to
higher production of acetic and n-butyric acid. High
concentrations of VFA are indicative of fermentations
by obligate anaerobic bacteria, reported to be an im-
portant source of energy for enterocytes and vital for
intestinal health (Sunkara et al., 2012). It has been re-
ported that increased concentrations of VFA lower the
intestinal pH, which is associated with suppression of
pathogens (Kubena et al., 2001, Rehman et al., 2007).
VFA not only affect host functions but also serve as
a carbon source for the endogenous bacteria, and at
high concentrations can exhibit toxic effects on bacte-
ria. Chickens are omnivores, and the diversity of micro-
bial communities in their intestinal tracts is related to
their lifestyle. It has been proposed that the different
nutritional requirements for maintaining homeostasis of
the microbiota communities in the gut would be due to
different fermentable substrates available in the termi-
nal ilea (Fang et al., 2012). Among the bacterial fer-
mentation end products in the chicken cecum, butyrate
is of particular importance because of its nutritional
properties for epithelial cells and pathogen inhibitory
effects in the gut (Sun and O’Riordan, 2013). In the
current study, the reduction in the proportion of acetic,
butyric, and valeric acids in the challenged unsupple-
mented control group (T1) could be due to C. jejuni. It
has been reported that Campylobacter colonization re-
duces butyrate, iso-butyrate, valerate, and iso-valerate
in the cecum (Awad et al., 2016).
Furthermore, translocation of E. coli to the liver,
spleen, and cecum increases in birds infected with C.
jejuni (Awad et al., 2016). Results from some of the
epidemiological studies also reported an increase of E.
coli in chicken carcasses that were infected with Campy-
lobacter (Duffy et al., 2014). The results from this study
suggest that Campylobacter infection may have an in-
fluence on the development of other microbial pop-
ulations, such as E. coli, illustrated by the data on
TYPLEX R© Chelate, used at higher doses. At 0.20 g/kg
feed, TYPLEX R© Chelate not only caused a 2.1 log10
cfu/g reduction in cecal C. jejuni colonization, but also
resulted in 1.2 log10 cfu/g reduction in E. coli popu-
lations. In a previous study, we found that inclusion
of TYPLEX R© Chelate in broiler diets without coc-
cidiostats caused a significant reduction in coccidial
oocyst counts and elevated the microbial dominance
at 52 to 54% guanine + cytosine in comparison with
non-supplemented diets, indicative of high-performing
healthy birds (Khattak et al., 2017). These results sup-
port the notion that TYPLEX R© Chelate may reduce
the activities of pathogenic bacteria but favor benefi-
cial bacteria and thus enhance growth performance. In
addition, the assessment of minimum inhibitory concen-
trations (MIC) of TYPLEX R© Chelate to C. jejuni, E.
coli, and Salmonella enterica showed that TYPLEX R©
Chelate did not inhibit the growth of these pathogens
(personal communications with Dr. Juha Apajalahti;
Alimetrics Group Ltd). The MIC values were higher
than 400 mg/L for C. jejuni and higher than 200 mg/L
for E. coli and Salmonella, indicating that none of the
enteric pathogens tested was inhibited by TYPLEX R©
Chelate at concentrations relevant for animal feed ap-
plications. It is possible that the TYPLEX R© Chelate
does not kill these pathogens but reduces their abil-
ity to adhere to the gut mucosa and thus lowers their
chances to compete with beneficial bacteria.
The addition of TYPLEX R© Chelate to the diet con-
sistently improved broiler AWG and FCR compared
to non-supplemented control birds. It has been re-
ported that C. jejuni can cause a significant decrease
in weight gain of poultry (Awad et al., 2014a) and that
there is a highly significant association between Campy-
lobacter positivity and poorer FCR (Sparks, 2016).
Campylobacter infection is found to significantly down-
regulate the gene expression of the sodium/glucose
cotransporter (SGLT-1), peptide transporter (PepT-
1), glucose transporter (GLUT-2), cationic amino acid
transporter (CAT-2), excitatory amino acid trans-
porter (EAAT-3), and the L-type amino acid trans-
porter (y+LAT-2) in different parts of the gut
(Awad et al., 2014b). Such decreased nutrient ab-
sorption not only explains the negative effect of
Campylobacter colonization on body weight, but this
also could be crucial for the persistence of Campy-
lobacter itself. To colonize and invade, C. jejuni
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bacteria require adequate nutrients, mainly amino acids
and Ca2+ (Fang et al., 2012; Awad et al., 2015).
Therefore, reduction in the intestinal uptake of nu-
trients by an avian host may increase carbon and
nitrogen sources that are essential for bacterial growth
(Guccione et al., 2008). The present study suggests
that TYPLEX R© Chelate also may promote growth per-
formance by enhancing intestinal nutrient absorption
and reducing colonization of C. jejuni. However, in ad-
dition to on-farm environmental conditions and host
immune response (Lin, 2009), any negative effects on
broiler body weights due to Campylobacter also could
be strain-specific, as different isolates of C. jejuni can
have different colonization potential (Hermans et al.,
2011).
In conclusion, the data from the current studies sug-
gest that TYPLEX R© Chelate reduces gut colonization
of C. jejuni by inhibiting biofilm formation, increases
the bacteriostatic effect of VFA, and improves intestinal
absorptive function. By reducing their adhesion power,
it is likely that the spread of C. jejuni through other bi-
ological and non-biological routes would be reduced. In
addition, disabling biofilm resistance may enhance the
ability of existing antibiotics to fight infections that are
refractory to current treatments and eventually help to
reduce human cases of Campylobacteriosis.
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